KENAN SAHBAZ: Open Payments
NPI 1285143545 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,952 in 39 payments from 9 companies in 2025. Trend: 2023 $3,565 · 2024 $4,713 · 2025 $4,952
Speaker / faculty: $4,300Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 22 | $4,601 |
| GENZYME CORPORATION | 7 | $148 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| JAZZ PHARMACEUTICALS INC. | 1 | $27 |
| Stryker Corporation | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Resmed Corp | 1 | $19 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $16 |
Products named: Xhance, DUPIXENT, Sunosi, NUCALA, XYWAV, SCOPIS ENT, AIRSENSE, LUMRYZ.
Industry payments across MO — which companies pay providers there.
